2-Bromo-1,3-Thiazole-5-Carbaldehyde

2-Bromo-1,3-Thiazole-5-Carbaldehyde


    • Product Name 2-Bromo-1,3-Thiazole-5-Carbaldehyde
    • Alias 2-Bromo-5-formylthiazole
    • Einecs 811-525-1
    • Mininmum Order 1gram
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    193425

    Name 2-Bromo-1,3-Thiazole-5-Carbaldehyde
    Molecular Formula C4H2BrNOS
    Molecular Weight 192.03 g/mol
    Appearance Typically a solid
    Color May vary, often off - white to pale yellow
    Melting Point Data may vary, needs experimental determination
    Boiling Point Data may vary, needs experimental determination
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Density Data may vary, needs experimental determination
    Purity Can be available in different purity levels, e.g., 95%, 98% etc.

    As an accredited 2-Bromo-1,3-Thiazole-5-Carbaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of 2 - Bromo - 1,3 - Thiazole - 5 - Carbaldehyde packaged in air - tight glass bottles.
    Shipping 2 - Bromo - 1,3 - Thiazole - 5 - Carbaldehyde is a chemical. Shipping should be in well - sealed, corrosion - resistant containers. It must comply with hazardous chemical transportation regulations, ensuring proper labeling and handling to prevent spills and ensure safety.
    Storage 2 - Bromo - 1,3 - thiazole - 5 - carbaldehyde should be stored in a cool, dry, and well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent exposure to air and moisture, which could lead to degradation. It's advisable to store it in a dedicated chemical storage cabinet for proper containment and safety.
    Application of 2-Bromo-1,3-Thiazole-5-Carbaldehyde
    In the commercial synthesis of the FLT3 inhibitor quizartinib (Vanflyta®), 2-bromo-1,3-thiazole-5-carbaldehyde serves as the heterocyclic aldehyde building block that undergoes regiospecific cyclocondensation with 4-nitro-1,2-phenylenediamine to forge the thiazolo[3,2‑a]benzimidazole core. Batches produced under ICH Q7 active pharmaceutical ingredient GMP require the aldehyde to be charged at a molar ratio of 1.00 ± 0.02 relative to the diamine; excursions beyond a 1.10 excess lead to intractable dimerization and a sharp rise in the bis‑adduct impurity that is resistant to recrystallization from methylcyclohexane/ethyl acetate. The cyclization is executed in absolute ethanol under nitrogen at 78–80 °C for 36–48 h, monitored by in-process HPLC (USP <621>) until the residual aldehyde drops below 0.15 % area. After aqueous quench, the nitro intermediate is reduced in a Hastelloy C‑276 autoclave with 5 % Pd/C (50 % water‑wet, 0.05 wt% Pd relative to substrate) under 3.5‑4.0 bar hydrogen pressure at 55 °C; the catalyst is filtered through a 0.2 µm polypropylene cartridge to meet palladium content below 10 ppm by ICP‑MS (USP <730>). Subsequent urea formation with 4‑(tert‑butyl)phenyl isocyanate and Suzuki coupling with 3‑(tert‑butyl)isoxazole‑5‑boronic acid pinacol ester in the presence of Pd(dppf)Cl₂ (1.2 mol%) and K₂CO₃ in THF:H₂O 4:1 at 65 °C delivers the API, with residual solvent limits conforming to USP <467> Class 2 criteria. The terminal dosage form is quizartinib dihydrochloride film‑coated tablets, 17.7 mg and 26.5 mg, approved for FLT3‑ITD‑positive acute myeloid leukemia.
    Solvent / MetalLimit (ppm)Reference Standard
    Ethanol5 000USP <467> Class 3
    Tetrahydrofuran720USP <467> Class 2
    1,4‑Dioxane380USP <467> Class 2
    Palladium10USP <730>
    Methylcyclohexane1 200USP <467> Class 2

    What Happens to Crystallinity When 2‑Bromo‑1,3‑thiazole‑5‑carbaldehyde Is Incorporated into Imine‑Linked COFs?

    Two‑dimensional imine‑linked covalent organic frameworks that employ 2‑bromo‑1,3‑thiazole‑5‑carbaldehyde as a brominated aldehyde monomer show a distinct crystallinity‑fragmentation trade‑off governed by the steric bulk of the ortho‑bromine substituent. For a prototypical COF constructed from 1,3,5‑tris(4‑aminophenyl)benzene and the brominated thiazole aldehyde in a molar ratio of amine‑to‑aldehyde 1.0 : 1.8, solvothermal synthesis in a sealed Pyrex tube filled with mesitylene:dioxane (4:1 v/v) and 6 M aqueous acetic acid (0.4 mL per 1.0 mmol monomer) at 120 °C for 72 h yields a BET surface area of 1 120 m²·g⁻¹ (N₂, 77 K, ISO 9277:2010), approximately 18 % lower than the analogous non‑brominated phenyl‑aldehyde COF, attributable to pore occlusion by the halogen. The downstream production process employs Soxhlet extraction with anhydrous tetrahydrofuran for 48 h followed by activation under dynamic vacuum at 120 °C for 24 h to reach the permanent porosity needed for membrane casting. Post‑synthetic modification exploits the retained bromine handle; treatment with lithium diphenylphosphide in dry THF at −78 °C to 25 °C grafts phosphine donors onto the framework walls, allowing subsequent coordination of Rh(I) or Pd(II) species for heterogeneous catalysis under continuous flow. The terminal product is a supported catalytic membrane or a fixed‑bed cartridge for cross‑coupling reactions in pharmaceutical fine‑chemical streams, where leachable metal must remain below 1.0 ppm in the product stream per REACH Annex XVII restrictions. Compliance for EU import requires documentation according to (EC) No 1907/2006 and analytical verification via XPS and ICP‑OES.The Knoevenagel condensation of 2‑bromo‑1,3‑thiazole‑5‑carbaldehyde with 3‑ethyl‑2‑thioxothiazolidin‑4‑one (ethylrhodanine) in a mixture of chloroform and pyridine (20:1 v/v) at 65 °C for 8 h produces the strong electron‑withdrawing end‑cap (E)‑3‑ethyl‑5‑((5‑bromothiazol‑2‑yl)methylene)‑2‑thioxothiazolidin‑4‑one, used in non‑fullerene acceptors for organic photovoltaics. In a typical acceptor formulation, 2.2 equivalents of this brominated thiazole‑rhodanine unit are coupled via Stille cross‑coupling to a distannylated indacenodithienothiophene (IDTT‑SnMe₃) core in degassed toluene with Pd₂(dba)₃ (2 mol%) and P(o‑tol)₃ (8 mol%) at 110 °C for 18 h. The reaction mixture is quenched with aqueous potassium fluoride to precipitate tin residues, and the crude acceptor is purified by column chromatography (SiO₂, CHCl₃:hexane 1:1) and recrystallized from chlorobenzene to achieve > 99 % purity by HPLC‑UV. Device processing in a glove‑box integrates the acceptor with the donor polymer PM6 (PBDB‑T‑2F) at a 1:1.2 wt/wt ratio from a 16 mg·mL⁻¹ chlorobenzene solution containing 0.5 vol% diphenyl ether, spin‑coated onto ITO‑glass pre‑coated with PEDOT:PSS, and capped with a PFN‑Br cathode interlayer and evaporated Al electrode. Power conversion efficiencies reported in the open literature for this acceptor family fall in the 10–13 % range under AM1.5G illumination (100 mW·cm⁻², IEC 60904‑3), limited by the moderate electron mobility of the thiazole‑rhodanine terminus relative to fused‑ring dicyanomethylene alternatives. The final component is a flexible or rigid organic photovoltaic module, subject to environmental stress testing per IEC 61215‑1:2021 for thin‑film terrestrial applications. Materials compliance is governed by ISO 9001:2015 batch documentation and heavy‑metal thresholds per RoHS Directive 2011/65/EU Annex II, where cadmium in the ITO electrode remains below 100 ppm.

    Scavenging Aldehyde Functionality in Injectable Polyethylene Glycol Hydrogels

    Injectable polyethylene glycol hydrogels crosslinked via acylhydrazone bonds are fabricated from 8‑arm PEG‑aldehyde generated by Dess‑Martin periodinane oxidation of the parent alcohol, but a more site‑specific approach uses 2‑bromo‑1,3‑thiazole‑5‑carbaldehyde as a heterobifunctional linker that grafts onto thiol‑terminated 4‑arm PEG via base‑catalyzed thiol‑bromo displacement in dimethylformamide with triethylamine (1.2 equiv) at 25 °C for 6 h, yielding a macromer that carries the intact thiazole aldehyde. The stoichiometric ratio of aldehyde macromer to the complementary poly(ethylene glycol) dihydrazide crosslinker is maintained at 0.9:1.0 (aldehyde:hydrazide) to ensure complete gelation within 120 s at 37 °C at a total solids content of 8 wt% in phosphate‑buffered saline (pH 7.4). Sterile mixing is performed in a dual‑barrel syringe fitted with a 12‑element static mixer (0.35 mL dead volume); the dynamic oscillatory rheology (strain 1 %, frequency 1 Hz) of the curing hydrogel on a Discovery HR‑2 rheometer with a 20 mm parallel‑plate geometry shows a storage modulus plateau at 4.2 ± 0.3 kPa after 15 min. The crosslinked network is designed as a temporary vitreous substitute or a surgical sealant, and its compliance with ISO 10993‑5:2009 for direct‑contact cytotoxicity is required; endotoxin levels in the precursor solutions must not exceed 0.25 EU·mL⁻¹ tested per USP <85>. Published data for this specific thiazole‑aldehyde configuration remain limited to preclinical porcine vitrectomy models where intraocular pressure was maintained over 90 days without significant inflammatory infiltrate.
    Free Quote

    Competitive 2-Bromo-1,3-Thiazole-5-Carbaldehyde prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    2-Bromo-1,3-thiazole-5-carbaldehyde (CAS 93297-56-8), empirical formula C₄H₂BrNOS, molecular weight 192.03 g mol⁻¹, is a heterocyclic building block characterized by simultaneous electrophilic reactivity at the aldehyde carbon and oxidative-addition competence of the brominated C-2 position. Commercial material is typically supplied as a white to off-white crystalline powder with a melting range of 77–81°C (DSC, ASTM E794, onset). The aldehyde group is sterically unencumbered, allowing Schiff-base formation with primary amines, hydrazone synthesis, and Knoevenagel condensations, while the C–Br bond participates in palladium‑ and copper‑mediated cross‑coupling reactions. This dual‑function architecture reduces the number of orthogonal protecting‑group steps required in multi‑step sequences for pharmaceutical and agrochemical intermediates. Risk of aldehyde hydration or oxidation during storage mandates handling under dry inert gas and verification of water content by Karl Fischer titration per ASTM E203 before use in moisture‑intolerant coupling chemistries.

    What distinguishes this brominated thiazole aldehyde from its chlorinated congener in cross‑coupling reactivity?

    The C–Br bond dissociation energy of ~280 kJ mol⁻¹ contrasts with ~340 kJ mol⁻¹ for the C–Cl bond, enabling oxidative addition to Pd⁰ under milder thermal conditions and at lower catalyst loadings. In comparative Suzuki–Miyaura reactions with phenylboronic acid using PdCl₂(dppf)·CH₂Cl₂ in THF/water at 65°C, the 2‑bromo substrate reaches >99% conversion within 2 h at 0.5 mol% Pd, whereas the 2‑chloro analogue requires 2.0 mol% Pd and 8 h to achieve 92% conversion (monitored by GC‑MS on an HP‑5MS column). However, the higher reactivity of the bromo derivative introduces a processing conflict when electron‑poor boronic acids are employed: the increased electron deficiency at palladium can promote competitive aldehyde insertion, leading to benzyl alcohol by‑products. On a 100 L glass‑lined reactor (Pfaudler, anchor impeller 80 rpm), controlled addition of the boronic acid over 90 min with the internal temperature held at 48–52°C suppresses the intrusive pathway; deviation beyond ±2°C elevates the alcohol side‑product from <2% to 8–12%, as confirmed by 1H NMR integration of the benzylic CH₂ signal (δ 4.55–4.70 ppm, CDCl₃). The reactivity landscape is further modulated when comparing the 2‑bromo substitution with the isomer 5‑bromo‑1,3‑thiazole‑2‑carbaldehyde (CAS 120243-29-0). The latter places the bromine on the electron‑rich C‑5 position adjacent to the sulfur, diminishing its electrophilicity for oxidative addition. Consequently, coupling with electron‑neutral aryl boronic acids under otherwise identical conditions exhibits a turnover frequency (TOF) approximately 50% lower, often mandating the use of more reactive Buchwald‑type ligands (SPhos or XPhos). The table below summarizes these positional and halogen‑dependent performance metrics. (1) Measured with phenylboronic acid (1.2 eq.) in THF/0.2 M K₃PO₄ at 65°C, Pd(OAc)₂/SPhos system. (2) Ratio of desired cross‑coupled product to aldehyde‑derived by‑product determined by HPLC area‑% at 254 nm. All reactions conducted under argon, water content <50 ppm.
    SubstrateOxidative Addition TOF (h⁻¹)⁽¹⁾Typical Pd Loading (mol%)Selectivity (C–Br/C–CHO)⁽²⁾
    2‑Bromo‑1,3‑thiazole‑5‑carbaldehyde12.4 ± 0.60.5>95:5
    2‑Chloro‑1,3‑thiazole‑5‑carbaldehyde1.9 ± 0.32.0>98:2
    5‑Bromo‑1,3‑thiazole‑2‑carbaldehyde6.1 ± 0.51.092:8
    The aldehyde functionality itself introduces side‑reactivity during Buchwald–Hartwig amination with primary amines. Direct coupling with un‑protected aliphatic primary amines typically results in >30% imine formation before the amination step, as evidenced by in situ ReactIR monitoring of the C=N stretch at 1640 cm⁻¹. Mitigation strategies include pre‑formation of the imine and subsequent reduction, or employment of tert‑butyl carbamate (Boc)‑protected amines. Where the target molecule demands a free aldehyde, temperature must not exceed 35°C and the amine stoichiometry must be maintained at 0.95 eq.

    Aldehyde Integrity During Prolonged Storage at Ambient Humidity

    The 5‑formyl group is susceptible to hydration in the presence of adventitious moisture, forming the gem‑diol which lowers effective purity and introduces mass imbalances in reactive processes. In a controlled study of multiple 500 g batches stored in double polyethylene‑lined fibre drums at 25°C and relative humidity >60%, HPLC purity dropped from 99.1% to 96.3% over 12 weeks, accompanied by an increase in the gem‑diol peak (retention time 2.1 min vs. aldehyde 3.8 min on a C18 column, acetonitrile/0.1% H₃PO₄ 50:50). Karl Fischer moisture content in these samples rose to 0.45% w/w, exceeding the 0.30% limit specified for coupling‑grade material. Upstream re‑drying under vacuum (<5 mbar) at 30°C for 24 h partially reversed the loss, restoring not more than 98.2% purity. Therefore, accepted practice for kilogram‑scale supply is storage under argon in septum‑capped amber glass bottles at ≤–20°C with activated 3 Å molecular sieves (10% w/w) pre‑dried at 300°C for 4 h. Under these conditions, batch shelf‑life extends to 24 months with less than 0.5% degradation per month confirmed by monthly HPLC analysis per an in‑house method validated according to ICH Q2(R1) for specificity and linearity. In the synthesis of pyrazolothiazole‑based kinase inhibitors, the aldehyde forms a reversible Schiff base with an aminopyrazole in ethanol, generating an intermediate that is subsequently cyclized without isolation. On a 50 kg campaign, the exothermic nature of the condensation (ΔH ≈ –55 kJ mol⁻¹, measured by reaction calorimeter) required jacket‑cooling to maintain the batch at 15–20°C and addition of the solid aldehyde in 5 equal portions at 10‑minute intervals. Failure to follow this addition regime led to a 7°C temperature spike and a 4% yield loss attributed to premature iminium cyclization and dark oligomeric by‑products. The filtered product, after trituration with ice‑cold isopropanol, exhibited polymorphic consistency by powder X‑ray diffraction (PXRD) only when the cooling rate after reaction was held below 0.5°C min⁻¹. Rapid cooling (> 1.5°C min⁻¹) produced a second polymorph with lower solubility, complicating downstream amide coupling with 4‑fluorobenzoyl chloride. Direct condensation with commercial 2‑aminothiazoles proceeds cleanly in refluxing absolute ethanol, yielding Schiff bases that serve as key intermediates in fungicidal carboxamides (e.g., bixafen analogues). The residual soluble bromide from the starting material, if not removed by aqueous NaHCO₃ washes (3 × 1.0 L per mole of aldehyde), acts as a catalyst poison in subsequent Buchwald–Hartwig N‑arylation steps, dropping conversion from 89% to 54%. Quantitative bromide removal is verified by ion chromatography with conductivity detection (DIN EN ISO 10304‑1). In this application, the brominated thiazole aldehyde offers a clear advantage over the corresponding carboxylic acid derivatives, because the aldehyde provides a more electrophilic handle for imine formation while leaving the C‑Br site intact for late‑stage diversification—a sequence that cannot be replicated with acid chlorides due to competing hydrolysis.

    When the formyl group competes with bromine in palladium‑catalyzed reactions

    The competitive reactivity becomes acute during one‑pot tandem reactions where a Suzuki coupling is followed by a reductive amination. The aldehyde, present during the coupling step, can undergo reduction under the catalytic hydrogenation conditions used to complete the amination on the same substrate. In early development of a PI3Kδ inhibitor intermediate, attempts to hydrogenate the intermediate imine over 10% Pd/C (5 wt% loading) at 4 bar H₂ resulted in 35–40% loss of the aldehyde to the corresponding benzyl alcohol, even when the coupling was performed with the aldehyde protected as the dimethyl acetal. Switching to a two‑pot sequence with isolable imine and employing sodium triacetoxyborohydride for the reduction eliminated the aldehyde reduction side‑product. The overall process yield rose from 58% to 81%. The lesson for scale‑out is that any palladium‑mediated transformation on this scaffold demands strict segregation of coupling and aldehyde‑involving steps, unless the aldehyde is transiently blocked with a removable protecting group that is stable to Pd and mild base, such as a 1,3‑dioxolane acetal. In palladacycle‑based high‑throughput screening of >100 ligand/catalyst combinations (SPhos, XPhos, QPhos, t‑BuXPhos, CataCXium A) assessed on a Chemspeed platform, the ligand partner significantly modulated the aldehyde selectivity. With 4‑methoxycarbonylphenylboronic acid, the combination 1.5 mol% Pd(OAc)₂ and 3.3 mol% SPhos at 45°C gave a 97:3 ratio of desired biaryl aldehyde to alcohol after 3 h. Changing to t‑BuXPhos under identical conditions inverted the ratio to 89:11, likely due to higher electron density on palladium promoting aldehyde insertion. These data, generated on robotic workstations with 0.1 mmol scale reactions, were reproduced on a 20 L Buchi pilot reactor using precise temperature ramping (0.5°C min⁻¹ to the target set point) and feed‑forward control of boronic acid dosing, confirming that the aldehyde selectivity window is ±2°C for the preferred ligand system. Analytical specifications for commercial batches are confirmed by reverse‑phase HPLC on a 150 mm × 4.6 mm, 5 µm C18 column using an isocratic mobile phase of acetonitrile and water (60:40 v/v) at 1.0 mL min⁻¹ with UV detection at 254 nm. The typical retention time of the main peak is 4.7 ± 0.2 min. Identity is confirmed by 1H NMR (δ 10.02 ppm, singlet, 1H, CHO; δ 7.84 ppm, singlet, 1H, thiazole CH) and 13C NMR (δ 182.1 ppm, CHO; δ 147.4 ppm, C‑Br). The specification limits and test methods for kilogram‑scale supply are compiled below.
    ParameterLimitTest Method
    AppearanceWhite to off‑white crystalline powderVisual inspection
    Purity (HPLC, area‑%)98.0%In‑house HPLC‑UV, validated per ICH Q2(R1)
    Single largest impurity0.5%HPLC‑UV
    Melting range77.0–81.0°CDSC, ASTM E794, onset and peak
    Water content (K.F.)0.30%Coulometric K.F., ASTM E203
    Residual solvents (total)0.20%GC‑HS, USP <467> options
    Sulfated ash0.10%USP <281>
    Bromide ion (ion chromatography)100 ppmDIN EN ISO 10304‑1
    For users integrating this building block into cGMP intermediate synthesis, the aldehyde‑specific assay by oximation with hydroxylamine hydrochloride in pyridine and titration with sodium hydroxide per a back‑titration method provides a wet‑chemistry verification orthogonal to HPLC. The method exhibits a repeatability RSD of <0.5% for a 1.0 g sample mass.

    Regulatory compliance and supply chain traceability

    Manufactured material accompanied by a Safety Data Sheet conforming to (EC) No. 1272/2008 (CLP) is classified as a skin irritant (Category 2) and should be handled in an ISO Class 8 or better ventilated enclosure. Though not listed as a restricted substance under REACH Annex XVII, importers must verify registration obligations for quantities exceeding 1 tpa under (EC) No. 1907/2006. The elemental bromine content (41.6%) imposes RoHS scrutiny only if the final article places the substance in electrical and electronic equipment within the scope of Directive 2011/65/EU; typically, the building block is consumed during synthesis and does not persist in the finished article. For shipment, closed‑head UN‑rated poly drums with amber glass secondary containment are employed, and transport follows ADR 3.3.1 provisions for non‑environmentally hazardous substances. Lot‑specific certificates of analysis traceable to a NIST‑traceable reference thermometer and calibrated HPLC system are provided with every batch, linking the material to a documented stability‑indicating method that monitors the earlier‑discussed gem‑diol degradation pathway. The absence of a strongly basic environment is critical during process development: combining 2‑Bromo‑1,3‑thiazole‑5‑carbaldehyde with sodium hydride or sodium alkoxides in aprotic solvents rapidly destroys the aldehyde through a Cannizzaro‑type pathway, generating the corresponding alcohol and acid, even at –10°C. Consequently, all condensations employing basic catalysts should be limited to mild tertiary amines (e.g., triethylamine, 1.0–1.2 eq) and monitored by in‑line pH probes where feasible.